AGP Picks
View all

Get your fresh news on health and wellness in New Hampshire

Provided by AGP

New Hampshire Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.

Press releases published on May 12, 2026

Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
CorVel Corporation to Host Live Earnings Release Webcast
Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
ProQR Announces First Quarter 2026 Operating and Financial Results
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
Immatics Announces First Quarter 2026 Financial Results and Business Update
NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
Sionna Therapeutics Reports First Quarter 2026 Financial Results
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update
Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour
Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma

Share us

on your social networks:

Sign up for:

New Hampshire Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.